Prophylactic actions of melatonin in oxidative neurotoxicity

Annals of the New York Academy of Sciences

Volumn 825, Issue , 1997, Pages 70-78

  Reiter, Russel J ^a   Guerrero, Juan M ^a   Escames, Germaine ^a   Pappolla, Miguel A ^a   Acuña Castroviejo, Dario ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; HYDROGEN PEROXIDE; KAINIC ACID; MELATONIN; MEMBRANE LIPID; POTASSIUM CYANIDE;

AGING; ALZHEIMER DISEASE; APOPTOSIS; CEREBELLUM; CONFERENCE PAPER; INTRAPERITONEAL DRUG ADMINISTRATION; LIPID PEROXIDATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; SEIZURE;

EID: 0030730368     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb48415.x     Document Type: Conference Paper

References (71)

1. HALLIWELL, B. 1992. Reactive oxygen species and the central nervous system. J. Neurochem. 59: 1609-1623.
2. MCCORD, J. M. & B. A. OMAR. 1993. Sources of free radicals. Toxicol. Ind. Heath 9:23-37.
3. REITER, R. J. 1995. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J. 9: 526-533.
4. PORTER, N. A., S. E. CALDWELL & K. A. MILLS. 1995. Mechanisms of free radical oxidation of unsaturated lipids. Lipids 30: 277-290.
5. 2+/ vitamin C - an appropriate in vitro model sytem to initiate lipid peroxidation. J. Inorg. Biochem. 61: 43-53.
6. BRIVIBA, K. & H. SIES. 1994. Nonenzymatic antioxidative defense systems. In Natural Antioxidants in Human Health and Disease. B. Frei, Ed. 107-128. Academic Press. San Diego.
7. Ahmad, S. 1995. Antioxidant mechanisms of enzymes and proteins. In Oxidative Stress and Antioxidative Defenses in Biology. S. Ahmad, Ed. 238-272. Chapman & Hall. New York.
8. IKEDA, Y., K. IKEDA & D. M. LONG. 1989. Protective effect of the iron chelator deferoximine on cold-induced brain edema. J. Neurosurg. 71: 233-238.
9. HARMAN, D. 1993. Free radical involvement in aging: pathophysiology and therapeutic implications. Drugs Aging 3: 60-80.
10. HARMAN, D. 1995. Free radical theory of aging: Alzheimer's disease pathogenesis. Age 18: 97-119.
11. REITER, R. J. 1991. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Res. 12: 151-180.
12. POEGGELER, B., R. J. REITER, D. X. TAN, L. D. CHEN & L. C. MANCHESTER. 1993. Melatonin, hydroxyl radical-mediated oxidative damage, and aging. J. Pineal Res. 14: 151-168.
13. REITER, R. J., D. MELCHIORRI, E. SEWERYNEK, B. POEGGELER, L. BARLOW-WALDEN, J. I. CHUANG, G. G. ORTIZ & D. ACUÑA-CASTROVIEJO. 1995. A review of the evidence supporting melatonin's role as an antioxidant. J. Pineal Res. 18: 1-11.
14. TAN, D. X., L. D. CHEN, B. POEGGELER, L. C. MANCHESTER & R. J. REITER. 1993. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr. J. 1: 57-60.
15. PIERI, C., M. MORRA, F. MARONI, R. RECCHIONI & F. MARCHESELLI. 1994. Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci. 55: PL271-PL276.
16. TAN, D. X., R. J. REITER, L. D. CHEN, B. POEGGELER, L. C. MANCHESTER & L. R. BARLOW-WALDEN. 1994. Both physiological and pharmacological levels of melatonin reduce DNA adduct formation induced by the carcinogen safrole. Carcinogenesis 15: 215-218.
17. MELCHIORRI, D., R. J. REITER, A. M. ATTIA, M. HARA, A. BURGOS & E. SEWERYNEK. 1994. Potent protective effects of melatonin on in vivo paraquat-induced oxidative damage in rats. Life Sci. 56: 83-89.
18. ABE, M., R. J. REITER, P. B. ORHII, M. HARA & B. POEGGELER. 1994. Inhibitory effect of melatonin on cataract formation in newborn rats: evidence for an antioxidative role for melatonin. J. Pineal Res. 17: 94-100.
19. HARDELAND, R., R. J. REITER, B. POEGGELER & D. X. TAN. 1993. The significance of the metabolism of the neurohormone melatonin: antioxidant protection and formation of bioactive substances. Neurosci. Behav. Rev. 17: 347-357.
20. POEGGELER, B., S. SAARELA, R. J. REITER, D. X. TAN, L. D. CHEN, L. C. MANCHESTER & L. R. BARLOW-WALDEN. 1994. Melatonin - a highly potent endogenous radical scavenger and electron donor: new aspects of the oxidation chemistry of this indole assessed in vitro. Ann. N. Y. Acad. Sci. 738: 419-420.
21. CHAN, T. Y. & P. L. TANG. 1996. Characterization of the antioxidant effects of melatonin and related indoleamines in vitro. J. Pineal Res. 20: 187-191.
22. MARSHALL, K. A., R. J. REITER, B. POEGGELER, O. I. ARUOMA & B. HALLIWELL. 1996. Evaluation of the antioxidant activity of melatonin in vitro. Free Radical Biol. Med. 21: 307-315.
23. ACUÑA-CASTROVIEJO, D., G. ESCAMES, M. MACIAS, A. MUÑOZ-HOYOS, A. MOLINA, CARBELLO, M. ARAUZO, R. MONTES & F. VIVES. 1995. Cell protective role of melatonin in the brain. J. Pineal Res. 19: 57-63.
24. PABLOS, M. I., M. T. AGAPITO, R. GUTIERREZ, J. M. RECIO, R. J. REITER & L. R. BARLOW-WALDEN. 1995. Melatonin stimulates the activity of the detoxifying glutathione peroxidase in several tissues of chicks. J. Pineal Res. 19: 111-115.
25. ANTOLIN, I. C. RODRIGUEZ, R. M. SAINZ, J. C. MAYO, H. URIA, M. L. KOLTER, M. J. RODRIGUEZ-COLUNGA, D. TOLIVIA & A. MENENDEZ-PELAEZ. 1996. Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidative enzymes. FASEB J. 10: 882-890.
26. PACKER, J. E., T. F. SLATER & R. L. WILLSON. 1979. Direct observation of free radical interaction between vitamin E and vitamin C. Nature 278: 737-738.
27. MENNENGA, K., M. UECK & R. J. REITER. 1991. Immunocytochemical localization of melatonin in the pineal gland and retina of the rat. J. Pineal Res. 10: 159-164.
28. MENENDEZ-PELAEZ, A. & R. J. REITER. 1993. Distribution of melatonin in mammalian tissues: the relative importance of nuclear verses cytosolic localization. J. Pineal Res. 15: 59-69.
29. MENENDEZ-PELAEZ, A., B. POEGGELER, R. J. REITER, L. R. BARLOW-WALDEN, M. I. PABLOS & D. X. TAN. 1993. Nuclear localization of melatonin in different mammalian tissues: immunocytochemical and radioimmunoassay evidence. J. Cell. Biochem. 53: 372-382.
30. REITER, R. J. 1995. The pineal gland and melatonin in relation to aging: a summary of the theories and of the data. Exp. Gerontol. 30: 199-212.
31. REITER, R. J. 1995. Oxygen radical detoxification processes during aging: the functional importance of melatonin. Aging Exp. Clin. Res. 7: 340-351.
32. REITER, R. J., B. A. RICHARDSON, L. Y. JOHNSON, B. N. FERGUSON & D. T. DINH. 1980. Pineal melatonin rhythm: reduction in aging Syrian hamsters. Science 210: 1372-1373.
33. REITER, R. J., C. M. CRAFT, J. E. JOHNSON, JR., T. S. KING, B. A. RICHARDSON, G. M. VAUGHAN & M. K. VAUGHAN. 1981. Age-associated reduction in nocturnal melatonin levels in female rats. Endocrinology 109: 1295-1297.
34. SACK, R. L., A. J. LEWY, D. L. ERB, W. M. VOLLMER & C. M. SINGER. 1986. Human melatonin production decreases with age. J. Pineal Res. 3: 379-388.
35. SKENE, D. J., B. VIVIEN-ROELS, D. L. SPARKS, J. HUNSAKER, P. PEVET, P. RAVID & D. F. SWAAB. 1990. Daily variation in the concentration of melatonin and 5-methoxytryptophol in the human pineal gland: effect of age and Alzheimer's disease. Brain Res. 528: 170-174.
36. MASORO, E. J. 1988. Food restriction in rodents: an evaluation of its role in aging. J. Gerontol. 43: B59-B64.
37. STOKKAN, K. A., R. J. REITER, K. O. NONAKA, A. LERCHL & D. J. JONES. 1991. Food restriction retards aging of the pineal gland. Brain Res. 545: 66-72.
38. REITER, R. J., D. X. TAN, B. POEGGELER, A. MENENDEZ-PELAEZ, L. D. CHEN & S. SAARELA. 1994. Melatonin as a free radical scavenger: implications for aging and age-related diseases. Ann. N. Y. Acad. Sci. 719: 1-12.
39. REITER, R. J., B. POEGGELER, L. D. CHEN, M. ABE, M. HARA, P. B. ORHII, A. M. ATTIA & L. R. BARLOW-WALDEN. 1994. Melatonin as a free radical scavenger: theoretical implications for neurodegenerative disorders of the aged. Acta Gerontol. 44: 92-114.
40. CHOI, D. W. 1988. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1: 623-634.
41. COYLE, J. T. & R. SCHWARCZ. 1976. Lesions of striatal neurons with kainic acid provides a model for Huntington's chorea. Nature 263: 244-246.
42. HALL, J. G., T. P. HICKS & H. MCCLENNAN. 1978. Kainic acid and the glutamate receptor. Neurosci. Lett. 8: 171-175.
43. MELCHIORRI, D., R. J. REITER, E. SEWERYNEK, L. D. CHEN & G. NISTICO. 1995. Melatonin reduces kainate-induced lipid peroxidation in homogenates of different brain regions. FASEB J. 9: 1205-1210.
44. MELCHIORRI, D., R. J. REITER, L. D. CHEN, E. SEWERYNEK & G. NISTICÒ. 1996. Melatonin affords protection against kainate-induced in vitro lipid peroxidation in brain. Eur. J. Pharmacol. 305: 239-242.
45. GIUSTI, P., M. GUSELLA, M. LIPARTITI, D. MILANI, W. ZHU, S. VICINI & H. MANEV. 1995. Melatonin protects primary cultures of cerebellar granule neurons from kainate but not from N-methyl-D-aspartate excitotoxicity. Exp. Neurol. 131: 39-46.
46. GIUSTI, P., M. LIPARTITI, D. FRANCESCHINI, N. SCHIAVO, M. FLORANI & H. MANEV. 1996. Neuroprotection by melatonin from kainate-induced excitotoxicity in rats. FASEB J. 10: 891-896.
47. GIUSTI, P., D. FRANCESCHINI, M. PETRONE, H. MANEV & M. FLORANI. 1996. In vitro and in vivo protection against kainate-induced neurotoxicity by melatonin. J. Pineal Res. 20: 226-231.
48. UZ, T., P. GIUSTI, D. FRANCESCHINI, A. KHARLAMOVA & H. MANEV. 1996. Protective effect of melatonin against hippocampal DNA damage induced by intraperitoneal administration of kainate to rats. Neuroscience 73: 631-636.
49. MANEV, H., T. UZ, A. KHARLAMOV, C. M. CAGNOLI, D. FRANCESCHINI & P. GIUSTI. 1996. In vivo protection against kainate-induced apoptosis by the pineal hormone melatonin: effect of exogenous melatonin and circadian rhythm. Restor. Neurol. Neurosci. 9: 251-256.
50. BUTTKE, T. M. & P. A. SANDSTROM. 1994. Oxidative stress as a mediator of apoptosis. Immunol. Today 15: 7-10.
51. CAGNOLI, C. M., C. ATABAY, E. KHARLAMOVA & H. MANEV. 1995. Melatonin protects neurons from singlet oxygen-induced apoptosis. J. Pineal Res. 18: 222-226.
52. PAPPOLLA, M. A., M. SOS, R. J. BICK, R. A. OMAR, D. L. M. HICKSON-BICK, R. J. REITER, S. EFTHIMIOPOULOS, K. SAMBAMURTI & N. K. ROBAKIS. 1996. Oxidative damage and cell death induced by an amyloid peptide fragment is completely prevented by melatonin. In Alzheimer's Disease: Biology, Diagnosis and Therapeutics. K. Iqbal, B. Winkblad, T. Nishimura, M. Takeda & H. M. Wisniewski, Eds. John Wiley. New York. In press.
53. RICHARDSON, J. S. & Y. ZHOU. 1996. Oxidative stress in the production and expression of neurotoxic β-amyloid. Restor. Neurol. Neurosci. 9: 207-211.
54. IMLAY, J. A., S. M. CHIN & S. LINN. 1988. Toxic DNA damage by hydrogen peroxide through the Fenton reaction in vivo and in vitro. Science 240: 1302-1309.
55. 2-induced lipid peroxidation in homogenates of different rat brain regions. J. Pineal Res. 19: 51-56.
56. CHEN, L. D., D. MELCHIORRI, E. SEWERYNEK & R. J. REITER. 1995. Retinal lipid peroxidation in vitro is inhibited by melatonin. Neurosci. Res. Commun. 17: 151-158.
57. ARDELT, B. K., J. L. BOROWITZ, E. U. MADUH, S. L. SWAIN & G. E. ISOM. 1994. Cyanide-induced seizures and lipid peroxidation generation in neuronal cells. Toxicology 89: 127-137.
58. YAMAMOTO, H. A., & H. W. TANG. 1996. Preventive effect of melatonin against cyanide-induced seizures and lipid peroxidation in mice. Neurosci. Lett. 207: 89-92.
59. YAMAMOTO, H. A. & H. W. TANG. 1996. Antagonistic effect of melatonin against cyanide-seizures and acute lethality in mice. Toxicology 87: 19-24.
60. YAMAMOTO, H. A. & H. W. TANG. 1996. Melatonin attenuates L-cysteine-induced seizures and lipid peroxidation in the brain of mice. J. Pineal Res. 21: 108-113.
61. GRAHAM, D. G. 1978. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 14: 633-643.
62. OLANOW, C. W. 1990. Oxidation reactions in Parkinson's disease. Neurology 40(Suppl. 3): 32-37.
63. YOSHIKAWA, T. 1993. Free radicals and their scavengers in Parkinson's disease. Eur. Neurol. 33(Suppl. 1): 60-68.
64. MILLER, J. W., J. SELHUB & J. A. JOSEPH. 1996. Oxidative damage caused by free radicals produced during catecholamine autoxidation: protective effects of O-methylation and melatonin. Free Radical Biol. Med. 21: 241-249.
65. CAO, G., H. M. ALESSIO & R. G. CUTLER. 1993. Oxygen-radical absorbance capacity assay for antioxidants. Free Radical Biol. Med. 14: 303-311.
66. ACUÑA-CASTROVIEJO, D., A. COTO-MONTES, M. G. MONTI, G. G. ORTIZ & R. J. REITER. 1997. Melatonin is protective against MPTP-induced striatal and hippocampal lesions. Life Sci. 60: PL23-PL29.
67. PAPPOLLA, M. A., R. A. OMAR, K. S. KIM & N. K. ROBAKIS. 1992. Immunohistochemical evidence of oxidative stress in Alzheimer's disease. Am. J. Pathol. 140: 621-628.
68. BEHL, C., J. B. DAVIS, R. LESLEY & D. SCHUBERT. 1994. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77: 817-827.
69. GLENNER, G. G. 1988. Alzheimer's disease: its protein and genes. Cell 52: 307-308.
70. HARRIS, M. E., K. HENSLEY, D. A. BUTTERFIELD, R. A. LEEDLE & J. M. CARNEY. 1996. Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1-40) in cultured hippocampal neurons. Exp. Neurol. 131: 193-202.
71. REITER, R. J., M. I. PABLOS, T. T. AGAPITO & J. M. GUERRERO. 1996. Melatonin in the context of the free radical theory of aging. Ann. N. Y. Acad. Sci. 786: 362-378.